Cheng-Ta Li, MD, PhD

  • 14Articles
  • 112.8KReads
  • 2017–2024Active
  • 48Collaborators
  • 563Citations

About

Cheng-Ta Li, MD, PhD, is affiliated with the Department of Psychiatry at Taipei Veterans General Hospital and the Division of Psychiatry, Faculty of Medicine, as well as the Institute of Brain Science at National Yang Ming Chiao Tung University in Taipei, Taiwan. Li has contributed to research on topics including child and adolescent psychiatry, bipolar disorder, depression, neurology, suicide, Alzheimer disease, and dementia. Li has published 14 articles between 2017 and 2024 in Psychiatrist.com, frequently collaborating with Mu-Hong Chen, Ya-Mei Bai, Shih-Jen Tsai, Tung-Ping Su, and Tzeng-Ji Chen.

Publications

JCP
Effects of Low-Dose Ketamine Infusion on Hopelessness and Suicidal Thoughts
Original Research

Effects of Low-Dose Ketamine Infusion on Hopelessness and Suicidal Thoughts

July 8, 2024

A single infusion of low-dose ketamine resulted in a brief (~4 hour) yet significant reduction in hopelessness.
, , , et al
JCP
Excess Mortality Associated With Schizophrenia
Original Research

Excess Mortality Associated With Schizophrenia

September 13, 2023

Females, patients with connective tissue disorders, and those aged 20 years or younger were especially impacted by the effect of schizophrenia on increasing mortality.
, , , et al
JCP
Original Research

Coaggregation of BD-I/BD-II With Major Psychiatric Disorders

September 7, 2021

Etiologic differences between bipolar I and II disorders have been challenged recently. This study used a large nationwide database to determine the risk of familial aggregation of specific psychiatric...
, , , et al
JCP
Original Research

OCD and Dementia Risk

May 11, 2021

Case reports suggest a link between obsessive-compulsive disorder (OCD) and dementia, but this association has received little research. The current study investigated dementia risk among OCD patients using a...
, , , et al
JCP
Original Research

Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response

November 10, 2020

Can we determine which patients will respond to ketamine just by observing their mood during the infusion? This study evaluated antidepressant outcomes with ketamine in 71 patients, focusing on ...
, , , et al
JCP
Original Research

Esketamine Nasal Spray Plus for Depression

April 28, 2020

Read a study about esketamine nasal spray (oral antidepressant) and it's long-term safety, tolerability, and efficacy for treatment-resistant depression (TRD).
, , , et al
JCP
Original Research

Prenatal Acetaminophen Exposure and ADHD Risk

September 10, 2019

Should a pregnant woman take acetaminophen? Learn the specific trimesters when consumption places the child most at risk for later being diagnosed with ADHD and whether other factors, like...
, , , et al
JCP
Original Research

Mortality Prediction Model for Dementia Patients

June 11, 2019

Using an 11-year follow-up of a population-based retrospective cohort, a risk score model identified 11 acute and chronic factors to predict mortality for dementia patients. A suitable care plan...
, , , et al
JCP
Original Research

Mental Disorders in First-Degree Relatives of ADHD Patients

April 30, 2019

Small-scale studies have shown that ADHD and severe psychiatric disorders are commonly clustered within families. Read this article to learn if this relationship held true in a large population-based...
, , , et al
JCP
Article

Bipolar Disorder and Sexually Transmitted Infection

March 12, 2019

What are some risk factors for (and protective factors against) sexually transmitted infections among adolescents and young adults with bipolar disorder?
, , , et al
JCP
Original Research

Type 2 Diabetes in Youths With SGA Exposure

March 5, 2019

Do kids who take second-generation antipsychotics have the same risk of developing type 2 diabetes as adults taking these drugs? In this longitudinal follow-up study of over 91,000 adolescents...
, , , et al
JCP
Original Research

ADHD and Type 2 Diabetes Mellitus

May 1, 2018

Anecdotal evidence suggests that risk factors related to type 2 diabetes mellitus—including obesity, hypertension, and dyslipidemia—may be associated with attention-deficit/hyperactivity disorder. This study looked at this possible relationship more...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe